Searched for
MERCK KEYTRUDA EXCLUSIVITY
Merck braces for Keytruda patent loss with $6.7 billion Terns betMerck is acquiring Terns Pharma for $6.7 billion to strengthen its cancer drug pipeline, aiming to reduce reliance on its blockbuster Keytr...- US-based Warburg Pincus in talks to buy Maneesh Pharma unit in Rs 1,800 crore dealUS private equity firm Warburg Pincus is nearing a deal to buy Maneesh Pharmaceuticals' non-tuberculosis drug business. The acquisition is ...
- Merck & Co to create a separate cancer unit as patent cliff loomsMerck & Co is restructuring by splitting its drug division into two separate businesses. The change is designed to spotlight its fastest-gr...
- Biopharma Shakti: India targets China dependence, patent cliffIndia is launching a major initiative to boost its biopharmaceutical manufacturing. This plan aims to reduce reliance on China for crucial ...
- Nasdaq big crash today: Nasdaq falls over 400 points, wipes out $1.1 trillion as AI stocks tumble — why AI shares are fallingNasdaq big crash today: Nasdaq falls over 400 points as AI stocks tumble. The Nasdaq Composite crashed 422.49 points today. This 1.79% drop...
- China’s biotech is redrawing the global pharma map; what India can learnAmerican biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...
- This drug may replace chemotherapy, redefine cancer careThese drugs will attack cancer cells in the body without damaging surrounding healthy ones.
- Merck wants to give products to Indians at affordable prices: Kenneth Frazier, Merck & CO"I see the progress made by the Modi administration towards not only ensuring that India can meet the needs of its people in healthcare, bu...
Load More